Prof. Ying Sun 孙颖
Chief Physician, Professor
Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionCurrent positions:Deputy Director and Vice President, Sun Yat-sen University Cancer Center
Checked against a public report (2025-10). Positions change; the hospital's website is the final word.
Clinical focus: Clinical diagnosis, radiotherapy, and comprehensive treatment of head and neck tumors, with a focus on nasopharyngeal carcinoma.
Dr. Sun holds an MD from Sun Yat-sen University and completed training at William Beaumont Hospital, Michigan. Currently Deputy Director of Sun Yat-sen University Cancer Center and Professor in the Department of Radiotherapy, Dr. Sun specializes in intensity-modulated, image-guided, and adaptive radiotherapy for nasopharyngeal carcinoma.
Professional roles
- Vice Chair, Nasopharyngeal Carcinoma Committee, Chinese Society of Clinical Oncology (CSCO)
- Vice Chair, Committee on Tumor Big Data and Real-World Research, China Anti-Cancer Association
- Vice Chair, Nasopharyngeal Carcinoma Prevention and Treatment Branch, China International Exchange and Promotion Association for Medical and Healthcare
- Standing Committee Member, Nasopharyngeal Carcinoma Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Sun Ying). Papers usually list the name as Ying Sun or Sun Y.
Selected publications
355 papers on PubMed matched by name and affiliation; 40 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Clin Oncol, 2026 (senior author): Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update. PubMed 43008242
- Int J Radiat Oncol Biol Phys, 2026 (senior author): MedNext-Insight Model for Automated Metabolic Tumor Volume Delineation on Computed Tomography and Prognostic Value in Nasopharyngeal Carcinoma. PubMed 42144163
- Cyborg Bionic Syst, 2026 (senior author): Real-Time AI-Based Radiotherapy Planning for Nasopharyngeal Carcinoma: Development and Validation. PubMed 42158526
- Nature, 2026 (senior author): Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma. PubMed 41813900
- Radiother Oncol, 2025 (senior author): Harnessing deep learning to optimize induction chemotherapy choices in nasopharyngeal carcinoma. PubMed 40738344
- BMC Med Inform Decis Mak, 2025 (senior author): Deep learning-based delineation of whole-body organs at risk empowering adaptive radiotherapy. PubMed 40665308
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Artificial Intelligence-Empowered Multistep Integrated Radiation Therapy Workflow for Nasopharyngeal Carcinoma. PubMed 39708045
- JAMA, 2025 (senior author): Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial. PubMed 40079940
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion